ISSN : 2832-0395

LOGIN

BEST PAPER AWARDS

Onco Studies Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here

INSTRUCTIONS TO AUTHORS

[1] Writing a Paper

Paper should be written, following the Instructions/Pattern given in Template for Writing a Paper.

See the Template for Writing a Paper [click here]


[2] Submission of Paper:

AUTHOR GUIDELINES:

We accept Editorial, Research, Case Report, Review, Opinion, Short Communication, Mini Review, Letter to Editors articles for publishing with us.

Covering Letter

Author need to submit a cover letter before submitting the manuscript and it should follow the following information

  • Contribution for the research work should be summarized
  • Relation between new and previously published work should be established
  • Relation between new and previously published work should be established
  • Describe any prior interactions with Publisher regarding the submitted manuscript
  • Suggest the editors to handle the manuscript
  • Specify the reviewers name that you oppose

 

Manuscript Standards

  • File format: We accept all DOC, PDF, RTF, or DOCX formats. Microsoft Word documents should not be locked or protected.
  • Length: There is no restriction in manuscript length or word count, number of figures and supporting information. We encourage you to present and discuss your findings concisely.
  • Font : standard font and font size
  • Headings : Limit manuscript sections and sub-sections to 3 heading levels
  • Layout: Manuscript text should be double-spaced.
  • Footnotes : Footnotes are not permitted
  • Language : Manuscripts must be submitted in English
  • Abbreviations: Define abbreviations upon first appearance in the text. Do not use non-standard abbreviations unless they appear at least three times in the text. Keep abbreviations to a minimum
  • Nomenclature : Use correct and established nomenclature wherever possible
  • Units of measurement: Use SI units. If you do not use these exclusively, provide the SI value in parentheses after each value
  • Drugs : Provide the Recommended International Non-Proprietary Name
  • Species names: Write in italics (Write out in full the genus and species, both in the title of the manuscript and at the first mention of an organism in a paper. After first mention, the first letter of the genus name followed by the full species name may be used (e.g., H. sapiens).)
  • Genes, mutations, genotypes, and alleles: Write in italics. Use the recommended name by consulting the appropriate genetic nomenclature database

Manuscript Organization:

  • The manuscript should follow the following standard instruction for each element appears below. 
    We are organizing the manuscript in to 4 sections
  • Section I: Title page (Title, authors, and affiliations), Abstract, Introduction
  • Section II: Materials and Methods, Discussion, Results, Conclusions
  • Section III: Acknowledgments, References and Supporting Information Captions (if applicable)
  • Section IV: Figure captions are inserted immediately after the first paragraph in which the figure is cited. Figure files are uploaded separately.
  • Tables are inserted immediately after the first paragraph in which they are cited.
  • Supporting information files are uploaded separately.

Manuscript Title:

Submitted manuscript should follow the following criteria:

  • Title should be in Title Case (except articles, conjunctions and prepositions)
    Title should not exceed 250 character length
  • Specific, Precise, Descriptive and intelligible to readers outside the sphere.
  • Try to avoid Special characters like abbreviations for clinical Trials, reviews and meta-analyses abstract should include study design.

Author:

After Title write author names on the Title page and Authors are separated by comma and last name should be followed by conjunction ‘and’ On the title page, write author names in the following order:

  • First name (or initials, if used)
  • Middle name (or initials, if used)
  • Last name (surname, family name)
  • Each author need to mention affiliation and it includes university, department or organizational information and its address including country name. If an author has multiple affiliations, enter all affiliations on the title page only.

Corresponding author:

Corresponding author should be marked with asterisk (*) symbol.
One corresponding author should be designated in the submission system. However, this does not restrict the number of corresponding authors that may be listed on the article in the event of publication.
E-mail address for each corresponding author should be included in the Title Page of the Manuscript.
If there is author group on manuscript, please provide a note that describes where the full membership list is available for the readers.
Membership list can be listed in the Acknowledgments, in Supporting Information, or on the internet.

Group authorship:

If manuscript is submitted on behalf of organization or research group, include the consortium or group name in the author list, and include the full list of members in the Acknowledgments or in a Supporting Information file.
The corresponding author is responsible for making sure all authors approve the final manuscript before submission. Publisher will contact all authors by email at submission to ensure that they are aware of the submission.
Author names will be published exactly as they appear in the accepted manuscript.
Indicate affiliations by number only.
Affiliation footnotes should appear in numerical order at first mention. Please use the symbols provided in this document for other designations.
Numbers and symbols should be in superscript.
Do not include titles (Dr, PhD, Professor, etc.).

Affiliations:

Affiliations will be published as they appear in the accepted manuscript. Include each component in order of small to large (Department, Division, Section, Institution, City, State, and Country).
Do not include ZIP or Postal Codes, street addresses, or building/office numbers.
Do not use abbreviations (e.g. Dept.).
Do not list positions within an institution (e.g. Department Chair, Professor, etc.).
List each affiliation individually and in full.

 

 

 

Partials:

Paper is using partials folder to inject some common html files like header and footer.

Symbol

Name

Definition

Pilcrow (paragraph symbol)

1st set of equal contributors

&

Ampersand

2nd set of equal contributors

*

Asterisk

sadasd

#a

Pound/number sign

First Current address

#b

Pound/number sign

Second Current address

Dagger/Cross

Deceased

^

Caret

Consortium/Group Authorship

 

Authors:

John Doe1¶, Antonie Data1¶, Johannes van Stats1,#a, Marie Testperson2*, David Ribosome Jr.3,5, Gregory H.T. McBio4,#b , Angela Reviewerson1,2&, Marina Measure1&, on behalf of The Bunny Genome Sequencing Consortium^

Affiliations:

1 Department, Institution, City, State, Country
2 Department of Dermatology, Division of Rabbit Health, Section of Veterinary Medicine, St. Hare Hospital, San Francisco, California, United States of America
3 Department of Libraries and Archives, National Contemporary Bunny Museum, Lagomorph, Connecticut, United States of America
4 Department of Restoration, National Contemporary Bunny Museum, Lagomorph, Connecticut, United States of America
5 Department of Archaeology, Bunny University, Lagomorph, Connecticut, United States of America
#a Current Address: Department of Carrot Science, Bunny University, Lagomorph, Connecticut, United States of America
#b Current Address: Department of Canine Evasion, Bunny University, Lagomorph, Connecticut, United States of America
* Corresponding author E-mail: james@university.ed (MT) 
¶ These authors contributed equally to this work.
& these authors also contributed equally to this work.
^ Membership of the Bunny Genome Sequencing Consortium is provided in the Acknowledgments.
Abstract will appear after the Title Page on the manuscript and abstract should follow the following criteria for submission:

  • It should not exceed 300 words
  • It should be descriptive along with the Objective of the study
  • Explain study and model used without methodological details
  • Summarization of results
  • It should not include citations and abbreviations (If possible)

Introduction

The introduction should:

  • Introduction should be in to context and allow readers to know the aim and significance of the study.
  • Define the issues mentioned and why it is important
  • Include a short review of the key literature
  • Note any controversies within the scope of the research
  • Brief description about overall objective and aim of the work and comment
  • Conclusion about the overall work and comments about whether that aim was achieved

 

Materials and Methods:

In this section author should provide sufficient information to allow suitably skilled investigators to fully replicate your study. Guidelines and protocols for new methods should be explained in detail. If protocols and standard methods are well established, author needs to cite these articles properly in detail, but the submission should be include sufficient information to be understood independent of these references. In this section.

Brief Information should be provided in this section to allow other investigators to repeat brief but sufficient to allow other investigators to repeat the research
References should be mentioned wherever possible procedures appear
All organizations and individuals from where the materials are gathered should be listed
If any manuscript presents only theory in that case we can omit Materials and Method Section.
Websites that providing tutorial, personal or laboratory material are omitted from the articles.
None of the Materials and Methods may be placed in Supplemental Materials.
Units like International Standard unit system (SI System) and temperature in degrees Celsius should be implemented in the entire manuscript.

 

Results:

Results should provide all the content which supports the conclusion of the article.
In this section details of all experimental findings which are required to support the conclusion of the manuscript.
There is no limit for result section but content should not detract from the focus of the manuscript.
Content in this section should be written in past tense.
Results can be divided in to sub sections and content should be concise.
Experimental findings should be clear but succinctly the experimental findings

Acknowledgments

Those who contributed to the work but do not meet our authorship criteria should be listed in the Acknowledgments with a description of the contribution. 
Authors are responsible for ensuring that anyone named in the Acknowledgments agrees to be named.

Results, Discussion, Conclusions

The above mentioned sections can be separate or combined to produce mixed section. This section further can be divided in to subsections. This section doesn’t have any word limit but the content should be clear and accurate. 
Together, these sections should describe the results of the experiments, the interpretation of these results, and the conclusions that can be drawn. 
Authors should explain how the results relate to the hypothesis presented as the basis of the study and provide a succinct explanation of the implications of the findings, particularly in relation to previous related studies and potential future directions for research.

References

All research work available within the scope of the manuscript can be cited in the reference section. The acceptable work can be published in reference section from the following sources 
Published or accepted manuscripts
Manuscripts on pre-print servers, if the manuscript is submitted to a journal and also publicly available as a pre-print 
Do not cite the following sources in the reference list:
Unpublished work and manuscripts which are under review or u published work.
Instead, include those data as supplementary material or deposit the data in a publicly available database.
Personal communication data should be supported by a letter from the relevant authors. It should not include in the references. 
References are published in the end of manuscript and order should be maintained as per text reference number in the bracket (citations).
Do not include citations in abstracts or author summaries.
Make sure the parts of the manuscript are in the correct order before ordering the citations.

Supporting Information:

Author needs to submit all supporting information including images or figures, tables, charts, graphs and other multimedia files. All these files subject to peer review process and are submitted along with manuscript and are not more than 10 MB in size.
Supporting files should be publication-ready, as they are not copyedited.

File format: We accept all DOC, PDF, RTF, or DOCX formats. Microsoft Word documents should not be locked or protected.

Length: There is no restriction in manuscript length or word count, number of figures and supporting information. We encourage you to present and discuss your findings concisely.

Font: standard font and font size

Headings: Limit manuscript sections and sub-sections to 3 heading levels

Layout: Manuscript text should be double-spaced

Footnotes: Footnotes are not permitted

Language: Manuscripts must be submitted in English

Abbreviations: Define abbreviations upon first appearance in the text. Do not use non-standard abbreviations unless they appear at least three times in the text. Keep abbreviations to a minimum

Nomenclature : Use correct and established nomenclature wherever possible

Units of measurement:  Use SI units. If you do not use these exclusively, provide the SI value in parentheses after each value

Drugs: Provide the Recommended International Non-Proprietary Name

Species names: Write in italics (Write out in full the genus and species, both in the title of the manuscript and at the first mention of an organism in a paper. After first mention, the first letter of the genus name followed by the full species name may be used (e.g., H. sapiens).)

Genes, mutations, genotypes, and alleles: Write in italics. Use the recommended name by consulting the appropriate genetic nomenclature database

Galley Proofs:

Electronic proofs will be sent (e‐mail attachment) to the corresponding author as a PDF file. Page proofs are considered to be the final version of the manuscript. With the exception of typographical or minor clerical errors, no changes will be made in the manuscript at the proof stage. Authors will have free electronic access to the full text (in both HTML and PDF) of the article.

Authors can freely download the PDF file from which they can print unlimited copies of their articles.

 

Transfer of Copyright Agreement:

Submission of a manuscript implies: that the work described has not been published before (except in the form of an abstract or as part of a published lecture, or thesis) that it is not under consideration for publication elsewhere; that if and when the manuscript is accepted for publication, the authors agree to automatic transfer of the copyright to the publisher.

All accepted manuscript must be accompanied by a signed copyright form to progress through to the final stages of production.

Fees and Charges: For the articles which authors submit for publication in AJETI would not be charged any publication fees. However, authors only upon acceptance of their manuscript are required to pay the processing, handling & evaluation and peer reviewing fee as mentioned in the publication charges. Payment details and mode of payment will be communicated to the authors by Editorial Coordinator of the journal as an acceptance letter by email. Publication of an article is not contingent upon the author’s ability to pay the charges.  Neither is acceptance to pay the handling fee a guarantee that the paper will be accepted for publication. Authors may still request (in advance) that the editorial office waive  some  of  the  handling fee under special circumstances.

EDITORIAL GUIDELINES

All manuscripts submitted by authors are treated with transparent and fair & honesty 
Editors are responsible for the guidelines stated as per the journal policies and authorship criteria.
Protecting the conflicts of interest for all in the publication process including editors, authors and reviewers.
Editor is responsible for the confidentiality of the manuscripts submitted by the author. 
Assigning reviewers to the manuscripts or articles submitted by the author for effective and rapid review process 
Editorial discussions and decisions are made with reasonable time and speed in a clear and constructive manner. 
Being vigilant in avoiding the possibility of editors and/or referees delaying a manuscript for suspect reasons 
Editor is responsible for maintaining the publication ethics and acceptable practices for sharing experimental materials and information 
Establishing a procedure for reconsidering editorial decisions 
Articles submission will be evaluated according to the journal guidelines and standard procedures. 
Developing mechanisms, in cooperation with the publisher, to ensure timely publication of accepted manuscripts 
clearly communicating all other editorial policies and standards 
Editors are responsible (decision making) for the acceptance or rejection of the manuscripts and also suggest possible changes for acceptance. 
Verify facts, dates, and statistics, using standard reference sources. 
Review and approve proofs submitted by composing room prior to publication production.

 

REVIEW GUIDELINES

Deciding Whether to Review a Manuscript Conflict of Interest. Reviewers should not accept to review a manuscript if a conflict of interest exists per the AHA Conflict of Interest Policy (reviewer section begins on the bottom of page 4).
Examples of typical conflicts of interest are: strong
The reviewer has an ownership interest in a company that stands to benefit from the results reported in the manuscript.
The reviewer is currently collaborating with the author or has recently collaborated with the author (i.e. within the past 5 years).
The reviewer feels he or she cannot give an impartial and objective review, free from professional or personal bias. 
If you have questions regarding a potential conflict of interest, please contact the handling editor, and he/she will decide whether it is appropriate to review the manuscript.
Time: Please consider whether you can complete the review within 10 days. Also, after agreeing to complete a review, if unforeseen circumstances prevent the reviewer from completing within the allotted time, please contact the editor immediately.

Peer Review Process:

If you realize that a conflict of interest exists after the review process begins, please notify the handling editor immediately.

Ethical Responsibilities during the Review Process:

Confidentiality: The reviewer should maintain confidentiality about the existence and substance of the manuscript. It is inappropriate to share the manuscript or to discuss it in detail with others before publication. There are some exceptions, if approved by the editor. One example is that the reviewer may ask a colleague to collaborate on a review. However, your collaborator on the review should also agree to maintain confidentiality, and the editor should be informed of the participation of this additional person.
Reviewer Conduct: as stated in the Uniform Requirements (http://www.icmje.org/#peer), “Reviewers must not publicly discuss authors’ work and must not appropriate authors’ ideas before the manuscript is published. Reviewers must not retain the manuscript for their personal use and should destroy copies of manuscripts after submitting their reviews.” Knowledge of the content of confidential manuscripts should not be used for any other purpose unrelated to the reviewing of the manuscript.
Reporting Concerns: The reviewer also has the responsibility of noting any ethical concerns, not limited to but including suspected duplicate publication, fraud, plagiarism, or ethical concerns about the use of animals or humans in the research being reported.

Constructing a Review:

Rating a manuscript - In this section of the review form, the reviewer ranks the Novelty/Originality,
Scientific Importance/Impact,
Adequacy of Methods/Experimental Design,
Quality of Data/Presentation Results, and
Overall Scientific Priority of the manuscript based on the following scale:
Top 10 % = High Priority
Top 20% = Somewhat High Priority
Top 30% = Average Priority
Upper 50% = Somewhat Low Priority
Lower 50% = Low Priority
N/A = Does not apply to this paper

Manuscripts rated in the upper 20% are more likely to be accepted for publication. The reviewer also makes a recommendation for publication.
Indicate whether you have any concerns regarding the statistical analysis used or if there are any ethical considerations.

In confidential comments to the Editor - Summarize your reasons for your rating and recommendations. Provide specific comments regarding the original aspects of the work and its importance.
In comments to the Author - The comments to the author should not include any statements that indicate to the author your judgment as to the acceptability of the paper for publication. All comments should be stated in a constructive and helpful way. The reviewer should discuss the shortcomings and/or strengths of a study. Include in your critique your judgment of originality and scientific importance,
adequacy and length of the title,
adequacy of the abstract,
introduction, rationale and clarity of hypothesis
adequacy of experimental design and methods,
quality of data and presentation of results, including figures,
appropriateness of the authors’ interpretation of their data,
length and appropriateness of the discussion, and
Inclusion of recent and appropriate references. If possible, make specific recommendations for revisions.

We publish the special issues to draw attention to under-researched or controversial topics or to new emerging themes in international business. The special issues are invited from recognized experts with in the journal scope and to attract articles of the highest quality
The main objective of the special issues is to integrate and analyse current thinking and debates in a focused area of applied research in order to inform the decision-making and policy-making community.
We accept the proposal for special issues on topics that fall within the scope of the journal. Proposals for Special Issues should be submitted by the Lead Guest Editor of the Special Issue
A call for papers must be submitted together with the proposal. The proposal for the special issue must contain the following information:
Guest editors: a short biography of the guest editors with a focus on the expertise of the proposed topic and the involvement in relevant communities 
Deadlines: appropriate schedule stating the major dates including paper submission, acceptance notice, etc.
Topics: the most important topics related the proposed special issue must be listed List of reviewers: a list of the reviewers of the special issue (their names, links to their homepages and areas of expertise). It is mandatory that all related topics of the issue are covered by the group of reviewers
Distribution and promotion: a plan for the distribution and promotion of the issue and to attract quality submissions.
All proposals are subject to approval by the journal following a discussion of the proposed Special Issue among the journal’s Editorial Board. If approved, a Call-for-Papers for the Special Issue will be issued and posted online.
Special Issues are made freely available online to all interested readers leading to the maximum possible dissemination and recognition within the scientific community.

Responsibilities of Guest Editors
The Guest Editor(s) are responsible for the selection, commissioning, editing and provision of the final manuscripts to the Editors will normally be expected to provide a preface/ introduction to the issue
The Journal Editors will communicate directly with authors only in exceptional circumstances and at relevant points of the production process.
Guest Editors will be expected to update the Journal Editors regularly on the progress of the Special Issue and ensure that authors follow the Journal's presentation and referencing guidelines
Editor will be expected to ensure that all authors supply illustrations of an appropriate quality and that authors obtain all necessary copyright permissions. Relevant documentation should be provided with the final version of the Special Issue will be expected to proof-read the entire volume and to ensure that authors proof-read their contributions should provide full contact details, including email addresses, for all contributors

 SPECIAL ISSUE GUIDELINES:

We encourage the submission of proposals for special issues that will be path breaking and exciting for our international readership.

The normal size of special issues is a minimum of 5, maximum of 10 manuscripts (5-7,000 words each, including references).
We strongly encourage a diversity of authorship—especially in terms of country of authors (i.e. not all authors should be from the same country or region).
Conveners of special issues should formally submit a written proposal to any one of the editors that includes a summary of the topic, an argument about its intellectual merits and relation to current debates in social & cultural geography, a complete list of authors (full contact details), titles, abstracts, and a realistic timeline.
The editors will discuss the proposal as a collective. If approved, a single editor will handle all the manuscripts in the special issue (including the convener’s introduction).
Conveners should have their authors submit their individual anonymized manuscripts at roughly the same time (within a few days). Authors (not conveners) should submit to Manuscript Central. In their cover letter, authors should signal that the paper is part of a (named) special issue.
All papers will be refereed in exactly the same way standard We manuscripts are refereed (typically 3 anonymous reviews from around the globe). One editor will handle all the manuscripts. That editor will not be bound to use referees suggested by conveners.
Submitting a manuscript to a special issue does not guarantee acceptance. Papers succeed or fail on their own merits. The Editor’s decision is final.
If an accepted paper has been waiting in the batch-assignment pile for over 9 months, we may need to dissolve the special issue and publish accepted articles as standalone pieces. This is so that successful, timely authors are not penalized by tardy or unsuccessful papers.
Once all of the manuscripts have been accepted, the convener will submit an editorial introduction to the issue. It should not exceed 4,000 words (including references). This introduction normally will not be refereed, but it will be edited by the editor. This must happen quickly to keep things on schedule.

submit_medipharm@rediffmail.com  or submit_medipharm@rediffmail.com

The editor will acknowledge receipts of manuscripts submission from the corresponding author.


[3] Conviniences

There are no printing, subscription or membership charges for any author

Authors will have to pay the cost for publication as follows--

For the complete paper with number of authors 1 or more = Rs 1000.

(This is the discounted Cost towards processing, maintenance of paper in secured data storage system, databases, improving values of Journal, Advertising, Sponsorship, Various overhead expenses, Plagiarism software use charges, formatting charges, setting charges, employees salaries etc., Office maintenance, Ele, comp, net,web, Future DOI charges etc).


For International author: This charge is $ 40 per paper”.

Papers from Editorial Board members, Referees and some Quality papers are published Free of Cost”


Note: Articles appear in a normal print journal format on a computer screen and can be printed as such, with the corresponding journal page numbers.